Clal Biotechnology Industries Ltd. (TASE: CBI) today announced that Sight Diagnostics, a portfolio company of Anatomy, Clal Biotechnology’s investment fund for medical devices, had raised $28 million.
Read more on Globes here.
Clal Biotechnology Industries Ltd. (TASE: CBI) today announced that Sight Diagnostics, a portfolio company of Anatomy, Clal Biotechnology’s investment fund for medical devices, had raised $28 million.
Read more on Globes here.
![[Celeno in Videonet] How service providers can own the Gigabit home](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
